Overview
Thrombocytosis refers to an elevated platelet count above the normal range, which can be reactive or due to myeloproliferative disorders. It requires differentiation based on clinical context and laboratory parameters to guide appropriate management 12.Diagnosis
Platelet Count: Elevated platelet count (typically >450,000/μL) 12.
Platelet Distribution Width (PDW): Useful in distinguishing reactive thrombocytosis from myeloproliferative disorders; reference range 10.0%-17.9% 2.
Mean Platelet Volume (MPV): Often elevated in reactive thrombocytosis; consider in conjunction with PDW and platelet count 2.
Genetic Testing: Consider for identifying chromosomal abnormalities like 21q- deletion 4.Management
First-Line Treatments:
- Observation: For asymptomatic patients with mild thrombocytosis 1.
- Pharmacological Agents: Sulfinpyrazone for normalization of platelet aggregability within 4 days 3.
Adjunctive Treatments:
- Therapeutic Cytapheresis: Consider in medical emergencies for rapid cytoreduction, though evidence is limited and not universally codified 1.Special Populations
Pregnancy: Specific management guidelines not covered in provided abstracts.
Pediatrics: Specific management guidelines not covered in provided abstracts.
Elderly: Specific management guidelines not covered in provided abstracts.
Comorbidities: No specific recommendations provided for managing thrombocytosis in the context of comorbidities 1.Key Recommendations
Monitor PDW and MPV alongside platelet count for better differentiation between reactive and secondary thrombocytosis (Evidence: Moderate 2).
Consider sulfinpyrazone for patients with enhanced spontaneous platelet aggregation (Evidence: Strong 3).
Evaluate the use of therapeutic cytapheresis in acute settings with caution due to lack of robust comparative evidence (Evidence: Weak 1).References
1 Coffe C, Pouthier F, Barisien C, Slimane M, Sheytanova A. Therapeutic leukapheresis and thrombapheresis in medical emergencies. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2020. link
2 Farias MG, Schunck EG, Dal Bó S, de Castro SM. Definition of reference ranges for the platelet distribution width (PDW): a local need. Clinical chemistry and laboratory medicine 2010. link
3 Nenci GG, Agnelli G, Berrettini M, Parise P, Ballatori E. Inhibition of spontaneous platelet aggregation by sulfinpyrazone. Thrombosis and haemostasis 1979. link
4 Petit P, Van den Berghe H. A chromosomal abnormality (21q-) in primary thrombocytosis. Human genetics 1979. link